Importing Under the Microscope: What 6 Recent FDA Warning Letters Teach Us

Ensuring the safety of food products crossing United States borders is an intensive, risk-based administrative mandate. Regulatory compliance professionals know that the Foreign Supplier Verification Program (FSVP) regulations, enforced under 21 CFR part 1, subpart L, demand absolute precision. Unfortunately, a recent string of warning letters issued by the FDA reveals a widespread, systemic failure among food importers to grasp their core compliance duties. These citations across multiple entities highlight that a lack of structured verification can completely disrupt an import supply chain. Failure to systematically evaluate foreign producers leaves firms vulnerable to immediate administrative enforcement and severe operational gridlocks.  

Across the majority of these enforcement actions, including Great One Trading Inc. (importing fresh soy chips and mooncakes), Sahara Enterprise Inc. (importing dry dough mix and baklava), Baja Fresko Distributors Inc. (importing squash and cucumbers), ISA Produce Corporation, and Greenworld Food Express LLC (importing halwa pistachio and tahini), the fundamental violation was identical. These companies failed to develop, maintain, and follow an FSVP. They did not just suffer from poorly executed paperwork; they possessed no formal program whatsoever for their imported commodities. Under section 805 of the Federal Food, Drug, and Cosmetic Act, an importer must perform specific risk-based activities to verify that human food meets applicable U.S. public health standards. Treating FSVP compliance as an afterthought rather than a mandatory prerequisite to entry is a critical oversight that automatically categorizes imported food as misbranded or prohibited.  

While a complete lack of an FSVP program was the overarching trend, several unique findings underscore specialized compliance blind spots. 

  • Unsubmitted Documentation: Zap Expo Center Inc. did technically reply to its Form FDA 483a observation and promised to build an FSVP within five months. However, the FDA deemed this response inadequate because the firm failed to submit any immediate supporting documentation or evidence of corrective action. Furthermore, internal records revealed a failure to obtain mandatory written assurances from suppliers at required intervals.  
  • The Communication and VSI Failure: The most distinct operational breakdown occurred with JMT Inter LLC. Instead of a standard on-site inspection issue, this firm failed to comply with electronic record-sharing mandates. Despite claiming Very Small Importer (VSI) status during phone conversations and receiving written “Requests for FSVP Records” (Form FDA 482d), the owner completely failed to transmit documentation electronically. This reminds professionals that status exemptions do not eliminate the baseline obligation to communicate and deliver files promptly when requested. 

Another recurring theme in these warning letters is the unacceptable trend of asking the FDA for extended grace periods after a violation is found. Importers like ISA Produce Corporation responded to auditors by stating they would have documentation ready “in one year or less,” while Greenworld Food Express LLC requested the “maximum time allowed” to build a compliant framework. The FDA categorically rejected these delay tactics. Regulatory professionals must understand that corrective action timelines are expected to be immediate, typically within 15 working days. Promising future compliance without providing concrete interim records is a losing strategy that leaves your inventory exposed to Import Alerts and Detention Without Physical Examination (DWPE).  

Ultimately, maintaining supply chain integrity requires proactive compliance rather than reactive promises. Regulatory professionals must view these collective warnings as an urgent call to audit their existing supplier verification frameworks. Waiting for an official FDA inspection to begin drafting a verification program is a recipe for regulatory disaster. If your firm acts as the U.S. importer of record, you must actively own the verification process from day one. Protecting your brand and your consumers requires nothing less than absolute compliance vigilance. 

Author

FDA Purán Newsletter Signup

Subscribe to FDA Purán Newsletter for 
Refreshing Outlook on Regulatory Topics